Original release date: December 16, 2019
Access to this course expires on: August 25, 2022 at 11:59 PM Pacific Time
Gastrointestinal pathology emerged as a subspecialty in the early 1980s, coincident with the development of endoscopy and mucosal biopsy for diagnosis and management of patients with gastrointestinal disorders. Since that time, changes in tissue acquisition techniques and ancillary testing have drastically transformed the discipline; current practice bears little resemblance to that of our mentors. The past two decades have seen an explosion in the number and types of biopsy samples pathologists encounter in daily practice. Virtually every part of the tubular gut is now amenable to visualization and sampling, and most liver biopsies are performed by radiologists who utilize small-caliber needles. As a result, pathologists are expected to generate comprehensive and accurate differential diagnoses for a variety of inflammatory and neoplastic disorders based on limited biopsy material. Pathologists must be able to hone in on key features in order to narrow the differential diagnosis and facilitate patient management.
Practicing academic and community pathologists, and pathologists-in-training
Upon completion of this educational activity, learners will be able to:
- Improve criteria for interpretation of mismatch repair protein immunohistochemistry
- Streamline utilization of ancillary tests in evaluation of lymphoid infiltrates of the GI tract
- Formulate an appropriate differential diagnosis for chronic hepatitis
- Distinguish between medication-related injury and other inflammatory conditions of the GI tract
- Explore various neoplasms that affect the gastrointestinal tract, liver and pancreas
Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 27.25
AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 20.5 SAM/Part II credit hours.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported a relevant financial relationship: David S. Klimstra, MD:
The following faculty and planners reported no relevant financial relationships: Rhonda Yantiss, MD; Henry D. Appelman, MD; Wendy L. Frankel, MD; John A. Hart, MD; Elizabeth A. Montgomery, MD
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME and SAM credit, all learners must complete the evaluation. View and print your certificate by
Buy the entire
Tutorial in Pathology of the GI Tract, Pancreas and Liver
course and receive a great discount!
Not A Member?